01 ALMOTRIPTAN MALATE (2)
01 JANSSEN PHARMS (2)
01 TABLET;ORAL (2)
01 EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (2)
19
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ALMOTRIPTAN MALATE, with a corresponding application number 21001 and regulatory information .
proudly manufactured in the
approval since 2001-05-07
Johnson & Johnson Innovative Medicine's AXERT TABLET;ORAL, medication with EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALMOTRIPTAN MALATE.
18
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ALMOTRIPTAN MALATE, with a corresponding application number 21001 and regulatory information .
proudly manufactured in the
approval since 2001-05-07
Johnson & Johnson Innovative Medicine's AXERT TABLET;ORAL, medication with EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALMOTRIPTAN MALATE.